Catasys, Inc. (CATS) Holdings Trimmed by Uniplan Investment Counsel Inc.

Uniplan Investment Counsel Inc. decreased its holdings in Catasys, Inc. (NASDAQ:CATS) by 3.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 263,920 shares of the company’s stock after selling 9,362 shares during the quarter. Uniplan Investment Counsel Inc. owned 1.64% of Catasys worth $2,472,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Vanguard Group Inc increased its position in shares of Catasys by 53.8% during the 3rd quarter. Vanguard Group Inc now owns 171,813 shares of the company’s stock valued at $2,208,000 after purchasing an additional 60,090 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Catasys by 53.8% during the 3rd quarter. Vanguard Group Inc. now owns 171,813 shares of the company’s stock valued at $2,208,000 after purchasing an additional 60,090 shares during the last quarter. B. Riley Wealth Management Inc. purchased a new stake in shares of Catasys during the 3rd quarter valued at about $217,000. Ancora Advisors LLC purchased a new stake in shares of Catasys during the 3rd quarter valued at about $191,000. Finally, Janney Montgomery Scott LLC increased its position in shares of Catasys by 9.7% during the 4th quarter. Janney Montgomery Scott LLC now owns 143,756 shares of the company’s stock valued at $1,347,000 after purchasing an additional 12,742 shares during the last quarter. 10.88% of the stock is owned by institutional investors and hedge funds.

CATS has been the subject of several research reports. TheStreet lowered shares of Catasys from a “c” rating to a “d+” rating in a research report on Wednesday, December 26th. Oppenheimer initiated coverage on shares of Catasys in a research report on Thursday, February 14th. They set an “outperform” rating and a $16.00 price target for the company. Zacks Investment Research lowered shares of Catasys from a “buy” rating to a “hold” rating in a research report on Tuesday, December 4th. ValuEngine raised shares of Catasys from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 1st. Finally, initiated coverage on shares of Catasys in a research report on Wednesday, February 13th. They set an “outperform” rating and a $16.00 price target for the company. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $15.20.

Shares of NASDAQ:CATS opened at $13.82 on Friday. The company has a market cap of $177.09 million, a P/E ratio of -16.26 and a beta of 1.95. Catasys, Inc. has a 12-month low of $4.21 and a 12-month high of $15.01.

Catasys (NASDAQ:CATS) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.16. The company had revenue of $5.62 million for the quarter, compared to the consensus estimate of $5.02 million. On average, research analysts predict that Catasys, Inc. will post -1.05 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Catasys, Inc. (CATS) Holdings Trimmed by Uniplan Investment Counsel Inc.” was first published by PressOracle and is the sole property of of PressOracle. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://pressoracle.com/news/2019/03/17/catasys-inc-cats-holdings-trimmed-by-uniplan-investment-counsel-inc.html.

About Catasys

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

Further Reading: Is a Roth IRA right for you?

Want to see what other hedge funds are holding CATS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catasys, Inc. (NASDAQ:CATS).

Institutional Ownership by Quarter for Catasys (NASDAQ:CATS)

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.